What does Sisophag do?
SISOPHAG specializes in innovative solutions for optimizing pharmaceutical and healthcare processes. The company focuses on providing software and services that enhance efficiency and compliance in the management of pharmaceutical products. Its mission is to support businesses in the healthcare sector to achieve better performance and safety in their operations.
- Sectors
- Garages Holding companies
- Signals
-
Reporting lossesReporting losses € -104K
The company reported a loss in the latest financial year.
Poor liquidityPoor liquidity 0.49The current ratio is below 1: may be insufficient to cover short-term debt.
Negative cashflowNegative cashflow € -9KOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -3KEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 1.99MStrong equity provides a buffer against setbacks.
Low riskLow risk 77.5%Good solvency (> 30%) points to long-term financial stability.
Healthy social debtHealthy social debt 18.4%Social debts stay manageable relative to personnel costs.
- Investments
- La Carrosserie Namuroise 100%, Gego 99,98%, Garage Max Gego Et Fils 99,67%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
959K
|
€
1.04M
|
€
1.02M
|
€
721K
|
|
|
€
-3K
|
€
130K
|
€
169K
|
€
89K
|
|
|
€
-111K
|
€
425K
|
€
675K
|
€
176K
|
|
|
€
1.99M
|
€
2.10M
|
€
1.68M
|
€
1.01M
|
|
|
77.53%
|
79.31%
|
63.34%
|
57.35%
|
|
|
€
578K
|
€
549K
|
€
972K
|
€
747K
|
|
|
€
9K
|
€
18K
|
€
185K
|
€
19K
|
|
|
2
|
2
|
2
|
1
|
Publications 20
All publications- Doel - Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) 12/10/2023
- Kapitaal - Aandelen - Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) 31/07/2020
- Ontslagen - Benoemingen 08/02/2018
- Me. - Jaarrekening 30.06.2016, Ggk 30.12.2016, Ngl 17.01.2017 17016-0144-028 20/01/2017
- Denomination - Siege Social - Statuts (Traduction, Coordination, Autres Modifications, ) 18/04/2016
Frequently asked questions
Answers to the most common questions about Sisophag, based on official government data and the filed annual accounts.
What is the VAT number of Sisophag?
The VAT number of Sisophag is BE0874.691.164.
How many employees work at Sisophag?
In 2025, Sisophag employed 2.00 full-time equivalents (FTE).
When was Sisophag established?
Sisophag was founded in 27-06-2005.
What is the official address of Sisophag?
The official address of Sisophag is Vindictivelaan 11/11 Oostende 8400.
What is the legal form of Sisophag?
The juridical form of Sisophag is Public limited company (NV/SA).
What is the annual revenue of Sisophag?
The revenue of Sisophag for the 2025 financial year was €958,526.
What does Sisophag do?
SISOPHAG specializes in innovative solutions for optimizing pharmaceutical and healthcare processes. The company focuses on providing software and services that enhance efficiency and compliance in the management of pharmaceutical products. Its mission is to support businesses in the healthcare sector to achieve better performance and safety in their operations.
Is Sisophag a reliable company?
Sisophag is a registered Rechtspersoon with company number 0874.691.164 and can be verified through the official CBE database.
What is the credit limit of Sisophag?
The estimated credit limit of Sisophag is €121,003.
Is Sisophag still active?
Sisophag currently has the status "Normal situation" and is active.